Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. Third Quarter Financial Summary [IFRS] (Consolidated)
Revenue was 2,042,439 hundred million yen, up 12.3% year-over-year for the same quarter. Segment profit was 436,884 hundred million yen, operating income was 423,733 hundred million yen, and quarter profit was 326,463 hundred million yen. Full-year forecasts were revised, and a share buyback and cancellation program was implemented. An earnings presentation will be held.
Key Figures
- Revenue: 2,042,439 hundred million yen
- Operating Income: 423,733 hundred million yen
- Quarter Profit: 326,463 hundred million yen
- Share Buyback and Cancellation: See separate attached materials for details
- Cash and Cash Equivalents at Period-End: 472,489 hundred million yen
AI要約
Overview of Performance
For the cumulative consolidated third quarter period, revenue was 2,042,439 hundred million yen, an increase of 12.3%. Growth was driven by continued strong performance of core products in the healthcare-related businesses, increased royalty income, and expansion of the new U.S. infusion business. By segment, Healthcare, Nutraceuticals, Consumer Products, and Others all recorded revenue increases. Research and development expenses rose by 4.7%, while overall investment continued. Full-year earnings guidance was revised, reflecting the impact of the share buyback and cancellation on earnings per share.
Financial Position and Cash
Total assets amounted to 4,323,273 hundred million yen, and equity was 3,285,658 hundred million yen. Cash and cash equivalents decreased to 472,489 hundred million yen. Operating cash flow was 334,168 hundred million yen, investing activities resulted in -206,203 hundred million yen, and financing activities resulted in -191,364 hundred million yen of cash outflow. Share buybacks and cancellations, bond redemptions, and dividend payments were executed. Shareholders' equity increased at period-end.
Otsuka Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
